TherapeuticsMD (TXMD) PT Lowered to $8 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St futures rise as AI stocks catch their breath; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts TXMD Hot Sheet
Price: $1.80 --0%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 19 | New: 16
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 19 | New: 16
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on TherapeuticsMD (NASDAQ: TXMD) to $8.00 (from $9.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Sanofi (SAN:FP) (SNY) PT Raised to EUR80 at RBC Capital
- China COSCO Holdings (1919:HK) (CICOY) PT Raised to HK$13.80 at Goldman Sachs
- Vanchip Tianjin Technology Co (688153:CH) PT Lowered to RMB22.40 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
